C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
12/2006
12/27/2006	EP1735267A1 Aminoalkyl substituted esters and amides of fumaric acid for neutralising malodor
12/27/2006	EP1734939A1 Anti-parasitic compounds and methods of their use
12/27/2006	EP1654324B1 Sulphonamide anions as catalysts for nco oligomerisation
12/27/2006	EP1480961B1 Glutaminyl based dpiv inhibitors
12/27/2006	EP1379515B1 Lipid lowering biphenylcarboxamides
12/27/2006	CN1886389A 喹喔啉化合物 Quinoxaline compounds
12/27/2006	CN1886135A Phenyl-piperazine derivatives as modulators of muscarinic receptors
12/26/2006	US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics
12/26/2006	US7153858 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
12/26/2006	US7153857 antiinflammatory agents; antiarthritic agents; anticancer agents
12/21/2006	WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	WO2006133904A2 Methods and intermediates for the preparation of optionally radio-labeled imatinib
12/21/2006	WO2006133588A1 ARYL UREA COMPOUNDS AS β-SECRETASE INHIBITORS
12/21/2006	WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/21/2006	WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof
12/21/2006	US20060287402 Cathepsin inhibitors
12/21/2006	US20060287389 Phenethanolamine derivatives for treatment of respiratory diseases
12/21/2006	US20060287338 Metalloproteinase inhibitor compounds
12/21/2006	US20060287306 Compounds to treat alzheimer's disease
12/21/2006	US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/21/2006	US20060287286 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent
12/21/2006	DE19843489B4 Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung Benzoylguanidine-derivatives having advantageous properties, to processes for their preparation and their use in the manufacture of medicinal products and pharmaceutical preparation containing them
12/21/2006	CA2612979A1 Parp modulators and treatment of cancer
12/21/2006	CA2610193A1 Methods and intermediates for the preparation of optionally radio-labeled imatinib
12/21/2006	CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative
12/20/2006	EP1734039A1 Aryl urea compounds as BETA-secretase inhibitors
12/20/2006	EP1734034A2 Carboxylic acid salts of beta-alanine esters or -amides
12/20/2006	EP1732909A1 Water soluble esters of ¬n-(4-amino-2-butynyl)\| with anticancer activity
12/20/2006	EP1732884A1 Sulphonamide derivatives
12/20/2006	EP1732610A2 Targeted serotonin reuptake inhibitors
12/20/2006	EP1567510B1 Method for producing salts of tolperisone
12/20/2006	EP1551822B1 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them
12/20/2006	EP1456171B1 Substituted cyclohexane derivatives
12/20/2006	CN1882548A pH sensitive prodrugs of 2,6-diisopropylphenol
12/20/2006	CN1882532A Aminoalkylamide substituted cyclohexyl derivatives
12/20/2006	CN1882528A Organic compounds
12/20/2006	CN1882332A Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	CA2264979C Dicyclic-aromatic compounds and their application in human and veterinary medicine, as well as in cosmetics
12/19/2006	CA2102035C Soluble anionic polymerization initiators and products therefrom
12/14/2006	WO2005089269A3 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
12/14/2006	US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
12/14/2006	US20060281759 selective serotonin receptor antagonists used for the treatment of psychological disorders such as schizophrenia and bipolar disorders, as anxiolytic agents and antidepressants; improved water solubility; side effect reduction;
12/14/2006	US20060281758 used for the treatment of psychological disorders such as schizophrenia, anxiety, depression and bipolar disorder
12/14/2006	US20060281757 Phenyl sulfone derivatives and their use in the treatment of cns disorders
12/14/2006	CA2610400A1 Azinone and diazinone v3 inhibitors for depression and stress disorders
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1730165A1 Inhibitors of hepatitis c virus ns3 protease
12/13/2006	EP1730148A2 Aminobenzoxazoles as therapeutic agents
12/13/2006	EP1730130A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
12/13/2006	EP1730123A1 Novel amination process
12/13/2006	EP1730103A1 Formamide derivatives useful as adrenoceptor
12/13/2006	EP1730099A2 Mitotic kinesin inhibitors
12/13/2006	EP1483241A4 Cyclic derivatives as modulators of chemokine receptor activity
12/13/2006	EP1148880B1 Methods for restoring and/or enhancing accommodation in pseudo phakia
12/13/2006	EP0738260B2 Pesticides
12/13/2006	CN1878554A 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289466C Pharmaceutical compounds
12/13/2006	CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same
12/12/2006	US7148355 Process for the preparation of repaglinide
12/12/2006	US7148259 hydroxyamidines; antibiotic resistance
12/12/2006	US7148251 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148238 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]piperidine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder.
12/12/2006	US7148198 Antibacterial agents
12/12/2006	US7148176 (adamantyl)nP(alkyl)m(1a); (adamantyl)o(Alkyl)qP (alkylene')P(adamantyl)r(alkyl)s , wherein adamantyl bonded to phosphorus atom in position 1, or 2, useful for refining halogenoaromatics
12/12/2006	CA2208439C Method for producing aminoethylethanolamine and/or hydroxyethyl piperazine
12/12/2006	CA2205390C Process for transporting a cellulose solution in an aqueous tertiary amine oxide
12/07/2006	WO2006130075A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006	WO2006103342A3 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/07/2006	WO2006014012A3 Aromatic compounds
12/07/2006	US20060276642 Compounds to treat Alzheimer's disease
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276467 Sodium channel modulators
12/07/2006	US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors
12/07/2006	CA2610671A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/06/2006	EP1728788A2 Fluorine-containing amide compound and method for preparing the same
12/06/2006	EP1728785A1 7-[(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-heptanoic acid ester 3,5-dioxo-acetal
12/06/2006	EP1727809A1 Substituted morpholine and thiomorpholine derivatives
12/06/2006	EP1727785A1 Phenyl indan derivatives
12/06/2006	EP1727782A1 Method of producing aminophenol compounds
12/06/2006	EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
12/06/2006	EP1079819B1 Hydroxamic acid derivatives as antibacterials
12/06/2006	CN1874777A 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/05/2006	USRE39419 Estrogen agonist/antagonist metabolites
12/05/2006	US7144911 Anti-inflammatory medicaments
12/05/2006	US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006	US7144884 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or piperazine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder.
12/05/2006	US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006	US7144881 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders
12/05/2006	CA2189652C Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same
11/2006
11/30/2006	WO2006127329A1 Quinoline derivatives useful as modulators of ion channels
11/30/2006	WO2006126635A1 Intermediate in production of [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound
11/30/2006	WO2006125596A1 Organic compounds for the treatment of imflammatory or alleric conditions
11/30/2006	WO2006109075A3 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
11/30/2006	US20060270738 Novel derivatives of 3,3-diphenylpropylamines
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	CA2609255A1 Intermediate in production of [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound

1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 341